Strategic Blueprint, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Strategic Blueprint, LLC

$1.49 Billion
Q3 2024

A detailed history of Strategic Blueprint, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Strategic Blueprint, LLC holds 4,087 shares of REGN stock, worth $2.92 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

4,087

Previous 4,123 0.87%

Holding current value

$2.92 Million

Previous $4.33 Million 0.85%

% of portfolio

0.29%

Previous 0.31%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $36,867 - $43,263	-36 Reduced 0.87%	4,087 $4.3 Million
Q2 2024 Jul 26, 2024	SELL	$883.2 - $1071.19 $46,809 - $56,773	-53 Reduced 1.27%	4,123 $4.33 Million
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $772,702 - $850,307	-856 Reduced 17.01%	4,176 $4.02 Million
Q4 2023 Jan 25, 2024	BUY	$775.18 - $881.7 $82,169 - $93,460	106 Added 2.15%	5,032 $4.42 Million
Q3 2023 Oct 18, 2023	BUY	$692.45 - $844.37 $204,272 - $249,089	295 Added 6.37%	4,926 $4.05 Million
Q2 2023 Oct 18, 2023	BUY	$700.03 - $830.35 $91,703 - $108,775	131 Added 2.91%	4,631 $3.33 Million
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $522,616 - $635,112	768 Added 20.58%	4,500 $3.7 Million
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $69,883 - $75,872	-99 Reduced 2.58%	3,732 $0
Q3 2022 Nov 08, 2022	SELL	$573.97 - $724.32 $646,290 - $815,584	-1,126 Reduced 22.72%	3,831 $2.64 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $93,219 - $125,602	-170 Reduced 3.32%	4,957 $2.93 Million
Q1 2022 Aug 12, 2022	SELL	$595.12 - $698.43 $3.79 Million - $4.45 Million	-6,372 Reduced 55.41%	5,127 $3.58 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $1.26 Million - $1.55 Million	2,312 Added 25.17%	11,499 $7.26 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $152,117 - $180,454	265 Added 2.97%	9,187 $5.56 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $2.11 Million - $2.5 Million	4,468 Added 100.31%	8,922 $4.98 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $1.99 Million - $2.44 Million	4,454 New	4,454 $2.11 Million
Q3 2020 Oct 27, 2020	SELL	$544.75 - $658.21 $266,382 - $321,864	-489 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$493.32 - $643.92 $241,233 - $314,876	489 New	489 $305,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Account

Strategic Blueprint, LLC Regeneron Pharmaceuticals, Inc. Transaction History